1. Encephalitis with Autoantibodies against the Glutamate Kainate Receptors GluK2. Issue 1 (17th May 2021) Authors: Landa, Jon; Guasp, Mar; Míguez‐Cabello, Federico; Guimarães, Joana; Mishima, Takayasu; Oda, Fumiko; Zipp, Frauke; Krajinovic, Vladimir; Fuhr, Peter; Honnorat, Jerome; Titulaer, Maarten; Simabukuro, Mateus; Planagumà, Jesus; Martínez‐Hernández, Eugenia; Armangué, Thais; Saiz, Albert; Gasull, Xavie... Journal: Annals of neurology Issue: Volume 90:Issue 1(2021) Page Start: 101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Glial Fibrillary Acidic Protein (GFAP) Antibody-Associated Astrocytopathy in Systemic Sarcoidosis. (5th December 2022) Authors: Matthews, Elizabeth; Smets, Ide; Kammeyer, Ryan; Titulaer, Maarten; Piquet, Amanda Journal: Neurology Issue: Volume 99:Number 23(2022)Supplement 2 Page Start: S57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Glial Fibrillary Acidic Protein (GFAP) Antibody-Associated Astrocytopathy in Systemic Sarcoidosis. (5th December 2022) Authors: Matthews, Elizabeth; Smets, Ide; Kammeyer, Ryan; Titulaer, Maarten; Piquet, Amanda Journal: Neurology Issue: Volume 99:Number 23(2022)Supplement 2 Page Start: S57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Glial Fibrillary Acidic Protein (GFAP) Antibody-Associated Astrocytopathy in Systemic Sarcoidosis. (5th December 2022) Authors: Matthews, Elizabeth; Smets, Ide; Kammeyer, Ryan; Titulaer, Maarten; Piquet, Amanda Journal: Neurology Issue: Volume 99:Number 23(2022)Supplement 2 Page Start: S57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Glial Fibrillary Acidic Protein (GFAP) Antibody-Associated Astrocytopathy in Systemic Sarcoidosis. (5th December 2022) Authors: Matthews, Elizabeth; Smets, Ide; Kammeyer, Ryan; Titulaer, Maarten; Piquet, Amanda Journal: Neurology Issue: Volume 99:Number 23(2022)Supplement 2 Page Start: S57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial. Issue 3 (March 2019) Authors: Wolfe, Gil I; Kaminski, Henry J; Aban, Inmaculada B; Minisman, Greg; Kuo, Hui-Chien; Marx, Alexander; Ströbel, Philipp; Mazia, Claudio; Oger, Joel; Cea, J Gabriel; Heckmann, Jeannine M; Evoli, Amelia; Nix, Wilfred; Ciafaloni, Emma; Antonini, Giovanni; Witoonpanich, Rawiphan; King, John O; Beydoun... Journal: Lancet neurology Issue: Volume 18:Issue 3(2019) Page Start: 259 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Pathologically confirmed autoimmune encephalitis in suspected Creutzfeldt-Jakob disease. Issue 6 (December 2015) Authors: Maat, Peter; de Beukelaar, Janet W.; Jansen, Casper; Schuur, Maaike; van Duijn, Cornelia M.; van Coevorden, Marleen H.; de Graaff, Esther; Titulaer, Maarten; Rozemuller, Annemieke J.; Sillevis Smitt, Peter Journal: Neurology Issue: Volume 2:Issue 6(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The ExTINGUISH Trial: A Phase-2B Randomized Placebo-Controlled Trial of Inebilizumab in Anti-NMDA Receptor Encephalitis. (5th December 2022) Authors: Wong, Ka-Ho; Day, Gregory; Titulaer, Maarten; Torner, James; Cudkowicz, Merit; Coffey, Christopher; Lungu, Codrin; Klawiter, Eric; Singleton, J.; Mitchell, Dana; Fedler, Janel; Ecklund, Dixie; Klements, David; Costigan, Michele; Clardy, Stacey Journal: Neurology Issue: Volume 99:Number 23(2022)Supplement 2 Page Start: S39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The ExTINGUISH Trial: A Phase-2B Randomized Placebo-Controlled Trial of Inebilizumab in Anti-NMDA Receptor Encephalitis. (5th December 2022) Authors: Wong, Ka-Ho; Day, Gregory; Titulaer, Maarten; Torner, James; Cudkowicz, Merit; Coffey, Christopher; Lungu, Codrin; Klawiter, Eric; Singleton, J.; Mitchell, Dana; Fedler, Janel; Ecklund, Dixie; Klements, David; Costigan, Michele; Clardy, Stacey Journal: Neurology Issue: Volume 99:Number 23(2022)Supplement 2 Page Start: S39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The ExTINGUISH Trial: A Phase-2B Randomized Placebo-Controlled Trial of Inebilizumab in Anti-NMDA Receptor Encephalitis. (5th December 2022) Authors: Wong, Ka-Ho; Day, Gregory; Titulaer, Maarten; Torner, James; Cudkowicz, Merit; Coffey, Christopher; Lungu, Codrin; Klawiter, Eric; Singleton, J.; Mitchell, Dana; Fedler, Janel; Ecklund, Dixie; Klements, David; Costigan, Michele; Clardy, Stacey Journal: Neurology Issue: Volume 99:Number 23(2022)Supplement 2 Page Start: S39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗